Literature DB >> 25156511

Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivity.

Sebastian Reuther1, Silke Szymczak, Annette Raabe, Kerstin Borgmann, Andreas Ziegler, Cordula Petersen, Ekkehard Dikomey, Ulrike Hoeller.   

Abstract

BACKGROUND AND
PURPOSE: The aim of this study was to determine the impact of functional single nucleotide polymorphism (SNP) pathways involved in the ROS pathway, DNA repair, or TGFB1 signaling on acute or late normal toxicity as well as individual radiosensitivity.
MATERIALS AND METHODS: Patients receiving breast-conserving surgery and radiotherapy were examined either for erythema (n = 83), fibrosis (n = 123), or individual radiosensitivity (n = 123). The 17 SNPs analyzed are involved in the ROS pathway (GSTP1, SOD2, NQO1, NOS3, XDH), DNA repair (XRCC1, XRCC3, XRCC6, ERCC2, LIG4, ATM) or TGFB signaling (SKIL, EP300, APC, AXIN1, TGFB1). Associations with biological and clinical endpoints were studied for single SNPs but especially for combinations of SNPs assuming that a SNP is either beneficial or deleterious and needs to be weighted.
RESULTS: With one exception, no significant association was seen between a single SNP and the three endpoints studied. No significant associations were also observed when applying a multi-SNP model assuming that each SNP was deleterious. In contrast, significant associations were obtained when SNPs were suggested to be either beneficial or deleterious. These associations increased, when each SNP was weighted individually. Detailed analysis revealed that both erythema and individual radiosensitivity especially depend on SNPs affecting DNA repair and TGFB1 signaling, while SNPs in ROS pathway were of minor importance.
CONCLUSION: Functional pathways of SNPs may be used to form a risk score allowing to predict acute and late radiation-induced toxicity but also to unravel the underlying biological mechanisms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156511     DOI: 10.1007/s00066-014-0741-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  39 in total

1.  Establishment of a Radiogenomics Consortium.

Authors:  Catharine West; Barry S Rosenstein; Jan Alsner; David Azria; Gillian Barnett; Adrian Begg; Søren Bentzen; Neil Burnet; Jenny Chang-Claude; Eric Chuang; Charlotte Coles; Kim De Ruyck; Dirk De Ruysscher; Alison Dunning; Rebecca Elliott; Laura Fachal; Janet Hall; Karin Haustermans; Carsten Herskind; Tobias Hoelscher; Takashi Imai; Mayumi Iwakawa; Don Jones; Cecilia Kulich; Jan-Hans Langendijk; Peter O'Neils; Mahmut Ozsahin; Matthew Parliament; Andrzej Polanski; Barry Rosenstein; Daniela Seminara; Paul Symonds; Chris Talbot; Hubert Thierens; Ana Vega; Catherine West; John Yarnold
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04       Impact factor: 7.038

2.  Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients.

Authors:  Jenny Chang-Claude; Odilia Popanda; Xiang-Lin Tan; Silke Kropp; Irmgard Helmbold; Dietrich von Fournier; Wulf Haase; Marie Luise Sautter-Bihl; Frederik Wenz; Peter Schmezer; Christine B Ambrosone
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

3.  Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.

Authors:  Kerstin Borgmann; Ulrike Hoeller; Sven Nowack; Michael Bernhard; Barbara Röper; Sophie Brackrock; Cordula Petersen; Silke Szymczak; Andreas Ziegler; Petra Feyer; Winfried Alberti; Ekkehard Dikomey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-01       Impact factor: 7.038

4.  A data-driven method for identifying rare variants with heterogeneous trait effects.

Authors:  Qunyuan Zhang; Marguerite R Irvin; Donna K Arnett; Michael A Province; Ingrid Borecki
Journal:  Genet Epidemiol       Date:  2011-08-04       Impact factor: 2.135

5.  Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy.

Authors:  David Azria; Mahmut Ozsahin; Andrew Kramar; Sheila Peters; David P Atencio; Nigel E A Crompton; Françoise Mornex; André Pèlegrin; Jean-Bernard Dubois; René-Olivier Mirimanoff; Barry S Rosenstein
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

Review 6.  [Prediction of the reaction of normal tissue and tumor cells to radiotherapy].

Authors:  E Dikomey; J Dahm-Daphi; L Distel
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

7.  Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.

Authors:  Monica Mangoni; Simonetta Bisanzi; Francesca Carozzi; Cristina Sani; Giampaolo Biti; Lorenzo Livi; Emanuela Barletta; Adele Seniori Costantini; Giuseppe Gorini
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-12       Impact factor: 7.038

8.  Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.

Authors:  E-M Thurner; S Krenn-Pilko; U Langsenlehner; W Renner; A Gerger; K S Kapp; T Langsenlehner
Journal:  Strahlenther Onkol       Date:  2014-01-16       Impact factor: 3.621

9.  Genetic predictors of long-term toxicities after radiation therapy for breast cancer.

Authors:  Nataliya Kuptsova; Jenny Chang-Claude; Silke Kropp; Irmgard Helmbold; Peter Schmezer; Dietrich von Fournier; Wulf Haase; Marie Luise Sautter-Bihl; Frederik Wenz; Kenan Onel; Christine B Ambrosone
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

10.  Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes.

Authors:  Christian Nicolaj Andreassen; Jan Alsner; Marie Overgaard; Jens Overgaard
Journal:  Radiother Oncol       Date:  2003-11       Impact factor: 6.280

View more
  3 in total

Review 1.  Inclusion of dosimetric data as covariates in toxicity-related radiogenomic studies : A systematic review.

Authors:  Noorazrul Yahya; Xin-Jane Chua; Hanani A Manan; Fuad Ismail
Journal:  Strahlenther Onkol       Date:  2018-05-17       Impact factor: 3.621

2.  BCL2 genotypes and prostate cancer survival.

Authors:  Wilfried Renner; Uwe Langsenlehner; Sabine Krenn-Pilko; Petra Eder; Tanja Langsenlehner
Journal:  Strahlenther Onkol       Date:  2017-04-10       Impact factor: 3.621

3.  Radiation Induced Lymphocyte Apoptosis: An Effective Way of "Tailoring" Radiotherapy to the Right Patients Only?

Authors:  Cesare Cozzarini
Journal:  EBioMedicine       Date:  2015-11-07       Impact factor: 8.143

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.